Molina Arturo MD

Chief Medical OfficerProtagonist Therapeutics, Inc (PTGX) · full profile →Form 4 · filed Nov 19, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$230K
Net Open-Market Flow
-$230K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 17, 2025Sell(S)3K$84.77$230K81K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-114082) within minutes of acceptance. Every field above traces to the original document. Verify it directly: